Toll-like Receptor-3 Stimulation Upregulates sFLT-1 Production by Trophoblast Cells

Placenta

Volumn 30, Issue 9, 2009, Pages 774-779

  Nakada, E ^a   Walley, K R ^a   Nakada, T ^a   Hu, Y ^b   von Dadelszen, P ^b   Boyd, J H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chemokines; Cytokines; Preeclampsia; sFLT 1; Toll like receptors

Indexed keywords

ANGIOGENESIS INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; LIGAND; RANTES; SOLUBLE FMS RELATED TYROSINE KINASE 1; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; STIMULATION; TROPHOBLAST;

ANALYSIS OF VARIANCE; CELL LINE; CHEMOKINE CCL5; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON REGULATORY FACTORS; INTERLEUKIN-6; LIGANDS; NF-KAPPA B; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTORS; TRANSFECTION; TROPHOBLASTS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 69549084457     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2009.07.001     Document Type: Article

References (32)

1. von Dadelszen P., and Magee L.A. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction?. Acta Obstet Gynecol Scand 81 (2002) 642-648
2. Redman C.W., and Sargent I.L. Pre-eclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta 24 Suppl. A (2003) S21-S27
3. Visser N., van Rijn B.B., Rijkers G.T., Franx A., and Bruinse H.W. Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv 62 (2007) 191-201
4. Kim Y.M., Romero R., Oh S.Y., Kim C.J., Kilburn B.A., Armant D.R., et al. Toll-like receptor 4: a potential link between "danger signals," the innate immune system, and preeclampsia?. Am J Obstet Gynecol 193 (2005) 921-927
5. Abrahams V.M., and Mor G. Toll-like receptors and their role in the trophoblast. Placenta 26 (2005) 540-547
6. Abrahams V.M., Visintin I., Aldo P.B., Guller S., Romero R., and Mor G. A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol 175 (2005) 8096-8104
7. Abrahams V.M., Bole-Aldo P., Kim Y.M., Straszewski-Chavez S.L., Chaiworapongsa T., Romero R., et al. Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol 173 (2004) 4286-4296
8. Mitsunari M., Yoshida S., Shoji T., Tsukihara S., Iwabe T., Harada T., et al. Macrophage-activating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E(2) via toll-like receptor 2 in human placental trophoblast cells. J Reprod Immunol 72 (2006) 46-59
9. Koga K., and Mor G. Expression and function of toll-like receptors at the maternal-fetal interface. Reprod Sci 15 (2008) 231-242
10. Kendall R.L., and Thomas K.A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A 90 (1993) 10705-10709
11. Kendall R.L., Wang G., and Thomas K.A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226 (1996) 324-328
12. He Y., Smith S.K., Day K.A., Clark D.E., Licence D.R., and Charnock-Jones D.S. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 13 (1999) 537-545
13. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
14. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
15. Graham C.H., Hawley T.S., Hawley R.G., MacDougall J.R., Kerbel R.S., Khoo N., et al. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 206 (1993) 204-211
16. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 (2001) 675-680
17. Beutler B., and Poltorak A. Sepsis and evolution of the innate immune response. Crit Care Med 29 (2001) S2-S6 (discussion S6-S7)
18. Yang I.A., Fong K.M., Holgate S.T., and Holloway J.W. The role of toll-like receptors and related receptors of the innate immune system in asthma. Curr Opin Allergy Clin Immunol 6 (2006) 23-28
19. Van Heel D.A., McGovern D.P., and Jewell D.P. Crohn's disease: genetic susceptibility, bacteria, and innate immunity. Lancet 357 (2001) 1902-1904
20. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., et al. Cutting edge: a novel toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the toll-like receptor signaling. J Immunol 169 (2002) 6668-6672
21. Brentano F., Schorr O., Gay R.E., Gay S., and Kyburz D. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll-like receptor 3. Arthritis Rheum 52 (2005) 2656-2665
22. Kariko K., Ni H., Capodici J., Lamphier M., and Weissman D. mRNA is an endogenous ligand for toll-like receptor 3. J Biol Chem 279 (2004) 12542-12550
23. Sen G.C., and Sarkar S.N. Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev 16 (2005) 1-14
24. DiFederico E., Genbacev O., and Fisher S.J. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 155 (1999) 293-301
25. Ishihara N., Matsuo H., Murakoshi H., Laoag-Fernandez J.B., Samoto T., and Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 186 (2002) 158-166
26. Roberts J.M., and Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 357 (2001) 53-56
27. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
28. Levine R.J., Lam C., Qian C., Yu K.F., Maynard S.E., Sachs B.P., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355 (2006) 992-1005
29. Gerber H.P., Condorelli F., Park J., and Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 272 (1997) 23659-23667
30. Nagamatsu T., Fujii T., Kusumi M., Zou L., Yamashita T., Osuga Y., et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145 (2004) 4838-4845
31. Ahmad S., and Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95 (2004) 884-891
32. Zhou C.C., Ahmad S., Mi T., Xia L., Abbasi S., Hewett P.W., et al. Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ Res 100 (2007) 88-95